✦ LIBER ✦

Pharmacokinetics of a Fixed-Dose Combination of Atorvastatin and Metformin Extended Release versus Concurrent Administration of Individual Formulations

✍ Scribed by Ms Kirti Kandhwal, Surajit Dey, Shabana Nazarudheen, Rachna Arora, Simrit Reyar, Nageshwar R. Thudi, Tausif Monif, Manoj K. Singh, Shireen Rao

Book ID: 118774709
Publisher: Springer International Publishing AG
Year: 2011
Tongue: English
Weight: 159 KB
Volume: 31
Category: Article
ISSN: 1179-1918
DOI: 10.1007/bf03256923

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of a Fixed-Dose Combina

Pharmacokinetics of a Fixed-Dose Combination of Mitiglinide and Metformin versus Concurrent Administration of Individual Formulations in Healthy Subjects

✍ Jin Ah Jung, Jung-Ryul Kim, Suk-Ran Kim, Tae-Eun Kim, Soo-Youn Lee, Jae-Wook Ko, 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 306 KB

Multiple Dose Pharmacokinetics of a New

Multiple Dose Pharmacokinetics of a New Once Daily Extended Release Tolterodine Formulation Versus Immediate Release Tolterodine

✍ Birgitta Olsson, Johan Szamosi 📂 Article 📅 2001 🏛 Springer International Publishing AG 🌐 English ⚖ 159 KB

Pharmacokinetics of isosorbide-5-mononit

Pharmacokinetics of isosorbide-5-mononitrate after oral administration of an extended-release mononitrate formulation versus a standard dinitrate formulation

✍ Teddy Kosoglou; James E. Patrick; Albert Cohen; Elaine Radwanski; David Christop 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 724 KB

The comparative bioavailability of an ex

The comparative bioavailability of an extended-release niacin and lovastatin fixed dose combination tablet versus extended-release niacin tablet, lovastatin tablet and a combination of extended-release niacin tablet and lovastatin tablet

✍ R. Menon; D. Tolbert; E. Cefali 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 1 views

Lovastatin and extended-release (ER) niacin in a fixed dose combination (Advicor 1 ) is approved for the treatment of dyslipidemia. Since both drugs are extensively metabolized, this study investigated the bioavailability and pharmacokinetics of their co-administration following single-dose administ

Pharmacokinetics and dose proportionalit

Pharmacokinetics and dose proportionality of extended-release metformin following administration of 1000, 1500, 2000 and 2500 mg in healthy volunteers

✍ Edward Cullen; James Liao; Peter Lukacsko; Robert Niecestro; Lawrence Friedhoff 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 2 views

Bioequivalence of Saxagliptin/Metformin

Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Subjects

✍ David W. Boulton, Charles H. Smith, L. Li, Jian Huang, Angela Tang, Frank P. LaC 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 186 KB